Rangers’ notes: Ogando hopes to avoid another trip to the disabled list

Posted Saturday, Aug. 17, 2013  comments  Print Reprints

Have more to add? News tip? Tell us

Alexi Ogando has been scratched from his scheduled start Monday, and it remains unknown whether he will require a third stint on the disabled list.

Ogando received a cortisone injection Saturday for the inflamed nerve in his right shoulder. The hope is that he will be able to miss only one start and avoid the DL.

Matt Garza will start on regular four days’ rest Monday, leaving Tuesday’s starter is to be determined. If Ogando doesn’t need to go on the DL, long man Ross Wolf could make a spot start.

The Rangers also have a couple options at Triple A Round Rock. Josh Lindblom, who has made five starts for the Rangers this season, is scheduled to start Sunday for the Express. Another option would be newly acquired left-hander Travis Blackley, who threw three scoreless innings over a 40-pitch outing on Thursday and would be on four days’ rest Tuesday.

“We’ll just see where we go,” manager Ron Washington said.

Ogando missed a month with right biceps tendinitis and another six weeks with right shoulder inflammation earlier this season. This latest setback is not related to either previous issue, but it has brought up questions about Ogando’s ability to hold up in the rotation.

Washington said it’s “premature” to say whether Ogando would return as a starter or reliever when he’s deemed healthy enough to pitch.

Mr. 300?

Yu Darvish said reaching the 300-strikeout mark doesn’t matter to him, but it would still be quite a feat.

Darvish has an outside chance to do it this season, which would be the first time a pitcher has recorded 300 strikeouts in a season since Randy Johnson and Curt Schilling each did back in 2002.

Darvish leads the majors with 207 strikeouts and is coming off a career-high 15-strikeout performance against the Houston Astros on Monday. He is expected to make eight more starts this season, including Sunday against Seattle, which means he would need to average 12 strikeouts per game to do it.

Through his first 23 games this season, Darvish has averaged nine strikeouts a start.

“Any time a pitcher can go through a season and get 300 strikeouts is a heck of a feat,” Ron Washington said. “What he’s doing right now is unbelievable. He’s facing good teams and getting double-figure strikeouts.”

Darvish, who turned 27 on Friday, has nine outings with 10 or more strikeouts.

Injury updates

Lance Berkman remains on the disabled list with left hip inflammation, and it appears more likely that the Rangers will wait until rosters expand on Sept. 1 to activate the 37-year-old designated hitter.

Berkman didn’t take batting practice for a third consecutive day on Saturday, and he still has good and bad days with his left hip and surgically repaired right knee.

“We’re still in limbo right now,” Ron Washington said.

The Rangers are content with their roster for now, which includes infielder Adam Rosales. Texas doesn’t have a backup utility infielder candidate in the minor leagues, which makes Rosales an attractive piece to keep rather than risk losing by designating him for assignment again.

In pitching news, reliever Neftali Feliz resumed his medical rehabilitation assignment Saturday by throwing a scoreless inning with one hit and one strikeout for Triple A Round Rock in Nashville. Feliz is rehabbing from Tommy John surgery and has also been slowed recently with mild triceps tendinitis.

Right-hander Nick Tepesch (right elbow inflammation) threw a 25-pitch bullpen session on Friday and said his arm felt good. He is scheduled to throw another bullpen session on Monday.

Drew Davison, 817-390-7760 Twitter: @drewdavison

Looking for comments?

We welcome your comments on this story, but please be civil. Do not use profanity, hate speech, threats, personal abuse, images, internet links or any device to draw undue attention. Our policy requires those wishing to post here to use their real identity.

Our commenting policy | Facebook commenting FAQ | Why Facebook?